We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yup... the way this is going they can have mine at £1.20 a share. I never thought that after jumping back in here again only a few months ago and with all the fantastic news since that I would be 45% down. So yes give me £1.20 and I will never look back.
IMO I’m convinced £90p is coming but not sure by what means. At a market cap of £90mil, surely some of the big players are wondering whether a buy out would make sense with £200mill a year solely for the US. I reckon £1.20 a share would do it!
New holdings consistent buys of betweeen £15,00 to £23,000 k comming in which IMO shows someone an entity or large buyer ammasing a position once they have filled up things will move and fast
Toli- what RNS are you expecting? Recent RNS’s have done nothing but destroy the SP & as BOD get shares allocated based on the last 10 days trading average in Dec price I don’t fancy there’s much chance of them releasing anything unless their forced into it?
Someone buying in its not the first time
I reckon an RNS will pop out soon and then things will take of
Interesting
Mars Paid 2 and half times the share price on monday
Mars just bought hotel Chocolate for £524million on revenues of Circa £200million and virtually no profit. obviously the brand counts . If Eroxon embeds then maybe .....
We now also have revenues significantly more than 1 year ago.
An RNS of how significantly more, and the updated forecast on revenues, is what the market is waiting on.
Plus share price has nose dived !!!
In the last twelve months the following has happened.
Launch in Europe.
Uk launch in Uk Boots.
FDA approval.
Haleon partnership.
Commercialisation in Saudi Arabia
Patent extension 30 years.
Launch in United Emirates.
Marketing approval in Mexico.
Now available through out UK(not just Boots)
Available through Amazon.
Tipped by Sunday Times.
Boots product of year.
Despite all the above the share price is less than it was a year ago.
I fail to see how next year’s expenditure is more that it’s income (JB stupid observation that FUM will not be in profit until 2025)
I notice that share options in other companies is dependent on the share price not on the 3 directors awarding themselves options that has no respect for the share holder base.
@Kingsmen,
We have discussed the reviews, at length on this BB over the summer.
We were of the opinion that the a lot of the reviews are probably fake. They all have similar tone, words and warnings to other buyers.
FUM mentioned the Boots reviews in one of their seminars and said the reviews seemed contrived.
Last time I looked on Boots there wasn't any new reviews for over a week.
The amount of reviews for Eroxon, compared to other ED treatments is also dispropotional.
All this led most people to believe that the reviews were left by a competitor product, or a disgruntled investor. Some of whom you'll find posting over on ADVFN.
Have you seen the reviews on amazon, expensive and doesn't work, will be watching this on the side, good luck
Hopefully usa news
Up 7% and more to come. £1.26 broker target. Lots of upside for those that get in now.
Fast jump to 40 Pence coming then 60 pence and onwards
Toli, we'll all be laughing just as much as you if any of your mad predictions come true, however we've been here too long and seen too many wild guesses go up in flames. It really doesn't serve any purpose, which is why people criticise your figures which you just pluck out of thin air, along with Ananda. It doesn't mean everyone is a stock basher just because they disagree with your wild optimism, we're just being realistic.
Lets see who has the last laugh
Now going for 33.2 pence.
Fill your boots before USA production and distribution news announced.
Back to 50 Pence in no time.
Jeeez Toli, pick a number, any number will do.
Toli, give it a break.
You have no idea what the sp will do. You’ve posted over 1000 times and have shown yourself to have nothing more than a very limited vocabulary which is limited to nothing more than outrageous speculative predictions.
£1.26 on the way
I wish you, others, and I well in this share Bandit1.
From what I see its moving very positively with the global rollout, supply chain(s) and reported sales progressing well. We seem to be gaining consumer awards on the way too.
Of course if you know more details to the contrary I'm sure this chat board would be glad to hear it, if you'd care to start a topic. Perhaps you could have your daughter assist with your requested research to continue your review and recomendations for the leadership team.
Good luck 👍
Banzai - perhaps you could outline what they are as there is very little by the way of achievements which I was able to find in a senior role? Being appointed a NED of a start up does not mean a great deal. Bottom line is that I have a significant amount invested here as I can see that the work Ken James did in obtaining the relevant approvals was first class and we have the potential with Eroxon to do very well indeed.
That potential will only be optimised with a team of experienced, astute and professional executives. As a small company we rely principally on Barder and Hildreth for commercial and financial matters. Can you understand why I am so keen that we employ the correct calibre of people to turn this opportunity into a successful one as many companies at our stage of development, fail due to an inability to identify the right people to unlock value? I just hope that Lombard Odier are all over this and exerting pressure as they have the most skin in this game.